1887

Abstract

Pneumococcal surface protein A (PspA) is an important vaccine candidate against pneumococcal infections, capable of inducing protection in different animal models. Based on its structural diversity, it has been suggested that a PspA-based vaccine should contain at least one fragment from each of the two major families (family 1, comprising clades 1 and 2, and family 2, comprising clades 3, 4 and 5) in order to elicit broad protection. This study analysed the recognition of a panel of 35 pneumococcal isolates bearing different PspAs by antisera raised against the N-terminal regions of PspA clades 1 to 5. The antiserum to PspA clade 4 was found to show the broadest cross-reactivity, being able to recognize pneumococcal strains containing PspAs of all clades in both families. The cross-reactivity of antibodies elicited against a PspA hybrid including the N-terminal region of clade 1 fused to a shorter and more divergent fragment (clade-defining region, or CDR) of clade 4 (PspA1–4) was also tested, and revealed a strong recognition of isolates containing clades 1, 4 and 5, and weaker reactions with clades 2 and 3. The analysis of serum reactivity against different PspA regions further revealed that the complete N-terminal region rather than just the CDR should be included in an anti-pneumococcal vaccine. A PspA-based vaccine is thus proposed to be composed of the whole N-terminal region of clades 1 and 4, which could also be expressed as a hybrid protein.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47661-0
2008-03-01
2020-07-11
Loading full text...

Full text loading...

/deliver/fulltext/jmm/57/3/273.html?itemId=/content/journal/jmm/10.1099/jmm.0.47661-0&mimeType=html&fmt=ahah

References

  1. Beall B., Gherardi G., Facklam R. R., Hollingshead S. K. 2000; Pneumococcal pspA sequence types of prevalent multiresistant pneumococcal strains in the United States and of internationally disseminated clones. J Clin Microbiol 38:3663–3669
    [Google Scholar]
  2. Brandileone M. C., Andrade A. L., Teles E. M., Zanella R. C., Yara T. I., Di Fabio J. L., Hollingshead S. K. 2004; Typing of pneumococcal surface protein A (PspA) in Streptococcus pneumoniae isolated during epidemiological surveillance in Brazil: towards novel pneumococcal protein vaccines. Vaccine 22:3890–3896 [CrossRef]
    [Google Scholar]
  3. Briles D. E., Hollingshead S. K., King J., Swift A., Braun P. A., Park M. K., Ferguson L. M., Nahm M. H., Nabors G. S. 2000; Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J Infect Dis 182:1694–1701 [CrossRef]
    [Google Scholar]
  4. Cherian T. 2007; WHO expert consultation on serotype composition of pneumococcal conjugate vaccines for use in resource-poor developing countries; 26–27 October 2006; Geneva. Vaccine 25:6557–6564 [CrossRef]
    [Google Scholar]
  5. Daniels C. C., Briles T. C., Mirza S., Hakansson A. P., Briles D. E. 2006; Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae . Microb Pathog 40:228–233 [CrossRef]
    [Google Scholar]
  6. Darrieux M., Miyaji E. N., Ferreira D. M., Lopes A. P. Y., Ren B., Briles D. E., Hollingshead S. K., Leite L. C. 2007; Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition. Infect Immun 75:5930–5938 [CrossRef]
    [Google Scholar]
  7. Heeg C., Franken C., van der Linden M., Al-Lahham A., Reinert R. R. 2007; Genetic diversity of pneumococcal surface protein A of Streptococcus pneumoniae meningitis in German children. Vaccine 25:1030–1035 [CrossRef]
    [Google Scholar]
  8. Hicks L. A., Harrison L. H., Flannery B., Hadler J. L., Schaffner W., Craig A. S., Jackson D., Thomas A., Beall B. other authors 2007; Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. J Infect Dis 196:1346–1354 [CrossRef]
    [Google Scholar]
  9. Hollingshead S. K., Becker R., Briles D. E. 2000; Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae . Infect Immun 68:5889–5900 [CrossRef]
    [Google Scholar]
  10. Hollingshead S. K., Baril L., Ferro S., King J., Coan P., Briles D. E. 2006; Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries. J Med Microbiol 55:215–221 [CrossRef]
    [Google Scholar]
  11. Ito Y., Osawa M., Isozumi R., Imai S., Ito I., Hirai T., Ishida T., Ichiyama S., Mishima M. 2007; Pneumococcal surface protein A family types of Streptococcus pneumoniae from community-acquired pneumonia patients in Japan. Eur J Clin Microbiol Infect Dis 26:739–742 [CrossRef]
    [Google Scholar]
  12. Jedrzejas M. J., Hollingshead S. K., Lebowitz J., Chantalat L., Briles D. E., Lamani E. 2000; Production and characterization of the functional fragment of pneumococcal surface protein A. Arch Biochem Biophys 373:116–125 [CrossRef]
    [Google Scholar]
  13. Kolberg J., Aase A., Michaelsen T. E., Rodal G. 2001; Epitope analyses of pneumococcal surface protein A: a combination of two monoclonal antibodies detects 94 % of clinical isolates. FEMS Immunol Med Microbiol 31:175–180 [CrossRef]
    [Google Scholar]
  14. McDaniel L. S., Ralph B. A., McDaniel D. O., Briles D. E. 1994; Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260. Microb Pathog 17:323–337 [CrossRef]
    [Google Scholar]
  15. Miyaji E. N., Ferreira D. M., Lopes A. P., Brandileone M. C., Dias W. O., Leite L. C. 2002; Analysis of serum cross-reactivity and cross-protection elicited by immunization with DNA vaccines against Streptococcus pneumoniae expressing PspA fragments from different clades. Infect Immun 70:5086–5090 [CrossRef]
    [Google Scholar]
  16. Mollerach M., Regueira M., Bonofiglio L., Callejo R., Pace J., Di Fabio J. L., Hollingshead S., Briles D. 2004; Invasive Streptococcus pneumoniae isolates from Argentinian children: serotypes, families of pneumococcal surface protein A (PspA) and genetic diversity. Epidemiol Infect 132:177–184 [CrossRef]
    [Google Scholar]
  17. Nabors G. S., Braun P. A., Herrmann D. J., Heise M. L., Pyle D. J., Gravenstein S., Schilling M., Ferguson L. M., Hollingshead S. K. other authors 2000; Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine 18:1743–1754 [CrossRef]
    [Google Scholar]
  18. Payne D. B., Sun A., Butler J. C., Singh S. P., Hollingshead S. K., Briles D. E. 2005; PspA family typing and PCR-based DNA fingerprinting with BOX A1R primer of pneumococci from the blood of patients in the USA with and without sickle cell disease. Epidemiol Infect 133:173–178 [CrossRef]
    [Google Scholar]
  19. Pimenta F. C., Ribeiro-Dias F., Brandileone M. C., Miyaji E. N., Leite L. C., Sgambatti de Andrade A. L. 2006; Genetic diversity of PspA types among nasopharyngeal isolates collected during an ongoing surveillance study of children in Brazil. J Clin Microbiol 44:2838–2843 [CrossRef]
    [Google Scholar]
  20. Ramos C. R., Abreu P. A., Nascimento A. L., Ho P. L. 2004; A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Braz J Med Biol Res 37:1103–1109
    [Google Scholar]
  21. Roche H., Hakansson A., Hollingshead S. K., Briles D. E. 2003; Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model. Infect Immun 71:1033–1041 [CrossRef]
    [Google Scholar]
  22. Sadowy E., Skoczynska A., Fiett J., Gniadkowski M., Hryniewicz W. 2006; Multilocus sequence types, serotypes, and variants of the surface antigen PspA in Streptococcus pneumoniae isolates from meningitis patients in Poland. Clin Vaccine Immunol 13:139–144 [CrossRef]
    [Google Scholar]
  23. Senkovich O., Cook W. J., Mirza S., Hollingshead S. K., Protasevich I. I., Briles D. E., Chattopadhyay D. 2007; Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein A provides insight into microbial defense mechanism. J Mol Biol 370:701–713 [CrossRef]
    [Google Scholar]
  24. Shaper M., Hollingshead S. K., Williams J. H. Jr, Briles D. E. 2004; PspA protects Streptococcus pneumoniae from killing by apolactoferrin and antibody to PspA enhances killing of pneumococci by apolactoferrin. Infect Immun 72:5031–5040 [CrossRef]
    [Google Scholar]
  25. Singleton R. J., Hennessy T. W., Bulkow L. R., Hammitt L. L., Zulz T., Hurlburt D. A., Butler J. C., Rudolph K., Parkinson A. 2007; Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska Native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297:1784–1792 [CrossRef]
    [Google Scholar]
  26. Tai S. S. 2006; Streptococcus pneumoniae protein vaccine candidates: properties, activities and animal studies. Crit Rev Microbiol 32:139–153 [CrossRef]
    [Google Scholar]
  27. Vela Coral M. C., Fonseca N., Castaneda E., Di Fabio J. L., Hollingshead J. K., Briles D. E. 2001; Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children. Emerg Infect Dis 7:832–836 [CrossRef]
    [Google Scholar]
  28. Yother J., Briles D. E. 1992; Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae , as revealed by sequence analysis. J Bacteriol 174:601–609
    [Google Scholar]
  29. Yother J., White J. M. 1994; Novel surface attachment mechanism of the Streptococcus pneumoniae protein PspA. J Bacteriol 176:2976–2985
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47661-0
Loading
/content/journal/jmm/10.1099/jmm.0.47661-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error